IRB review of international research. Pre-conference P1 FCPA 3 rd Party Due Diligence for Health Entities. Today
|
|
- Gwen Wiggins
- 6 years ago
- Views:
Transcription
1 John Heldens, CIP, CCRP Director, UCSF Health Care Compliance Association 2011 Compliance Conference IRB review of international research Pre-conference P1 FCPA 3 rd Party Due Diligence for Health Entities Today UCSF experience with international human research OHRP: IRB knowledge of local context Differences between FDA and ICH-GCP 2 1
2 UCSF Transnational 3 UCSF IRB members knowledge of international local research context Angola Argentina Australia Botswana Brazil Cambodia Canada Chile China Costa Rica Ecuador Egypt France Germany Guatemala Honduras India Ivory Coast Jamaica Japan Liberia Mexico Mozambique Netherlands New Zealand Nigeria Peru Poland Saint Vincent & the Grenadines South Africa Thailand Tobago Trinidad Turkey Uganda United Kingdom 4 2
3 IRB Knowledge of Local Context 5 45 CFR (a) The IRB shall be sufficiently qualified through the experience and expertise of its members, and the diversity of the members, including consideration of race, gender, and cultural backgrounds and sensitivity to such issues as community attitudes, to promote respect for its advice and counsel in safeguarding the rights and welfare of human subjects. In addition to possessing the professional competence necessary to review specific research activities, the IRB shall be able to ascertain the acceptability of proposed research in terms of institutional commitments and regulations, applicable law, and standards of professional conduct and practice. The IRB shall therefore include persons knowledgeable in these areas. 6 3
4 45 CFR (3) Selection of subjects is equitable. In making this assessment the IRB should take into account the purposes of the research and the setting in which the research will be conducted (4) Informed consent will be sought from each prospective subject or the subject's legally authorized representative (7) When appropriate, there are adequate provisions to protect the privacy of subjects 7 45 CFR no investigator may involve a human being as a subject in research covered by this policy unless the investigator has obtained the legally effective informed consent of the subject or the subject's legally authorized representative. An investigator shall seek such consent only under circumstances that provide the prospective subject or the representative sufficient opportunity to consider whether or not to participate and that minimize the possibility of coercion or undue influence. The information that is given to the subject or the representative shall be in language understandable to the subject or the representative. 8 4
5 (1) minimal risk research The IRB should demonstrate that it has obtained necessary information about the local research context through written materials or discussions with appropriate consultants. IRB application IRB members IRB Consultants 9 (2) No intervention/interaction, principal risk is breach of confidentiality The IRB should (i) demonstrate that it has obtained necessary information about the local research context through written materials or discussions with appropriate consultants; and (ii) determine and specifically document that provisions to protect the privacy of subjects and maintain the confidentiality of data are adequate. Reviewer s checklist 10 5
6 Necessary information the anticipated scope of the institution's research activities; the types of subject populations likely to be involved; the size and complexity of the institution; institutional commitments and regulations; applicable law; standards of professional conduct and practice; method for equitable selection of subjects; method for protection of privacy of subjects; method for maintenance of confidentiality of data; language(s) understood by prospective subjects; method for minimizing the possibility of coercion or undue influence in seeking consent; and safeguards to protect the rights and welfare of vulnerable subjects. 11 (3) Greater than minimal risk The IRB should demonstrate that it has obtained necessary information about the local research context through one or more of the following mechanisms, or through other mechanisms deemed appropriate by OPRR for the proposed research and the local research context. a) Personal knowledge of the local research context on the part of one or more IRB members, such knowledge having been obtained through extended, direct experience with the research institution, its subject populations, and its surrounding community. b) Participation (either physically or through audiovisual or telephone conference) by one or more appropriate consultants in convened meetings of the IRB. Such consultant(s) should have personal knowledge of the local research context, [as described above]. 12 6
7 (3) Greater than minimal risk c) Prior written review of the proposed research by one or more appropriate consultants (see (b) above), in conjunction with participation (see (b) above) by the consultant(s) in convened meetings of the IRB, when such participation is deemed warranted either by the consultant(s) or by any member of the IRB. d) Systematic, reciprocal, and documented interchange between the IRB and elements of the local research context. Such interchange should include (i) periodic visits to the research site, occurring several times per year, by one or more IRB members in order to obtain and maintain knowledge of the local research context (see (a) above); (ii) periodic discussion with appropriate consultants knowledgeable about the local research context; (iii) regular interaction with one or more designated institutional liaisons; and (iv) review of relevant written materials. 13 Institutional responsibilities 1) Each institution remains responsible for safeguarding the rights and welfare of human subjects within its local research context. 2) Each institution remains responsible for educating the members of its research community in order to establish and maintain a culture of compliance with Federal regulations and institutional policies relevant to the protection of human subjects. 3) Each institution remains responsible for implementation, within its local research context, of appropriate oversight mechanisms in order to ensure compliance with the determinations of the reviewing IRB. 4) Where institutions holding an OPRR-approved Assurance engage a separate entity to perform human subject protection activities, OPRR must review and approve those portions of the contract and/or other clarifying documentation detailing responsibilities and implementation mechanisms relevant to such activities. (a) (c) [documentation requirements] 14 7
8 Differences between FDA vs. ICH-GCP 15 Vulnerable subjects ICH-GCP (E6) 1.61 Examples are members of a group with a hierarchical structure, such as medical, pharmacy, dental, and nursing students, subordinate hospital and laboratory personnel, employees of the pharmaceutical industry, members of the armed forces, and persons kept in detention. Other vulnerable subjects include patients with incurable diseases, persons in nursing homes, unemployed or impoverished persons, patients in emergency situations, ethnic minority groups, homeless persons, nomads, refugees, minors, and those incapable of giving consent. 16 8
9 Modifications ICH-GCP (E6) The investigator should not implement any deviation from, or changes of the protocol without agreement by the sponsor and prior review and documented approval/favourable opinion from the IRB/IEC of an amendment, except where necessary to eliminate an immediate hazard(s) to trial subjects, or when the change(s) involves only logistical or administrative aspects of the trial (e.g., change in monitor(s), change of telephone number(s)). 17 Randomization ICH-GCP (E6) (c) The consent form and discussion should explain: The trial treatment(s) and the probability for random assignment to each treatment. 18 9
10 Subject s responsibilities ICH-GCP (E6) (e) The consent form and discussion should explain: The subject's responsibilities. 19 Alternatives ICH-GCP (E6) (i) The consent form and discussion should explain: The alternative procedure(s) or course(s) of treatment that may be available to the subject, and their important potential benefits and risks
11 Confidentiality ICH-GCP (E6) (n) The consent form and discussion should include a statement that: The monitor(s), the auditor(s), the IRB/IEC, and the regulatory authority(ies) will be granted direct access to the subject's original medical records for verification of clinical trial procedures and/or data, without violating the confidentiality of the subject, to the extent permitted by the applicable laws and regulations and that, by signing a written informed consent form, the subject or the subject's legally acceptable representative is authorizing such access. 21 Consent form signatures ICH-GCP (E6) Prior to a subject s participation in the trial, the written informed consent form should be signed and personally dated by the subject or by the subject's legally acceptable representative, and by the person who conducted the informed consent discussion
12 Witness ICH-GCP (E6) If a subject is unable to read or if a legally acceptable representative is unable to read, an impartial witness should be present during the entire informed consent discussion. After [informed consent] the witness should sign and personally date the consent form. By signing the consent form, the witness attests that the information in the consent form and any other written information was accurately explained to, and apparently understood by, the subject or the subject's legally acceptable representative, and that informed consent was freely given by the subject or the subject s legally acceptable representative. 23 Documentation to subjects ICH-GCP (E6) Prior to participation in the trial, the subject or the subject's legally acceptable representative should receive a copy of the signed and dated written informed consent form and any other written information provided to the subjects. During a subject s participation in the trial, the subject or the subject s legally acceptable representative should receive a copy of the signed and dated consent form updates and a copy of any amendments to the written information provided to subjects
13 Assent ICH-GCP (E6) When a clinical trial (therapeutic or nontherapeutic) includes subjects who can only be enrolled in the trial with the consent of the subject s legally acceptable representative (e.g., minors, or patients with severe dementia), the subject should be informed about the trial to the extent compatible with the subject s understanding and, if capable, the subject should sign and personally date the written informed consent. 25 Non-therapeutic trials ICH-GCP (E6) Non-therapeutic trials may be conducted in subjects with consent of a legally acceptable representative provided the following conditions are fulfilled: (a) The objectives of the trial can not be met by means of a trial in subjects who can give informed consent personally. (b) The foreseeable risks to the subjects are low. (c) The negative impact on the subject s wellbeing is minimized and low. (d) The trial is not prohibited by law
14 Non-therapeutic trials (e) The approval/favourable opinion of the IRB/IEC is expressly sought on the inclusion of such subjects, and the written approval/ favourable opinion covers this aspect. Such trials, unless an exception is justified, should be conducted in patients having a disease or condition for which the investigational product is intended. Subjects in these trials should be particularly closely monitored and should be withdrawn if they appear to be unduly distressed. 27 Federalwide Assurances FWA required for institutions receiving federal research funding FDA requires IRB/ERC registration 28 14
15 Resources IRB Knowledge of Local Context International Compilation of s pcompilation-v pdf ICH-GCP E6 Bankert, Elizabeth and Amdur, Robert. Institutional Review Board Management and Function. Sudbury, MA: Jones and Bartlett,
Dr. R. Sathianathan. Role & Responsibilities of Principal Investigators in Clinical Trials. 18 August 2015
18 August 2015 Role & Responsibilities of Principal Dr. R. Sathianathan Professor of Psychiatry, SRMC, Porur & Former Director, Institute of Mental Health, Chennai Principal Investigators & GOOD CLINICAL
More informationInstitutional Review Board Standard Operating Procedures. Education and Training on Human Subject Research Date Last Revised: OVERVIEW
Page 1 of 6 Document Number: IRB-P106 Version Number: 1.3 Institutional Official: David Carlisle, MD, PhD Title: Institutional Review Board Standard Operating Procedures Education and Training on Human
More informationFact sheet on elections and membership
Commission on Narcotic Drugs Commission on Crime Prevention and Criminal Justice Fact sheet on elections and membership States members of the CCPCJ and CND (and other functional commissions of the Economic
More informationInstitutional Review Board (previously referred to as Human Participants Research Board) Updated January 2004
Institutional Review Board (previously referred to as Human Participants Research Board) Updated January 2004 All research requests meeting the following conditions must be reviewed by the Institutional
More informationUniversity of Wyoming End of Semester Fall 2013 Students by Country & Site
Angola Angola Total Undergraduate Argentina Argentina Total Armenia Graduate/Professional Armenia Total Undergraduate 12 0 0 12 Australia Australia Total 12 0 0 12 Austria Graduate/Professional Austria
More informationAPEC Preliminary Workshop: Review of Drug Development in Clinical Trials
APEC Preliminary Workshop: Review of Drug Development in Clinical Trials Session 9 B Clinical Trial Assessment Patient Protection Informed Consent Susan D Amico Vice President and Global Head Clinical
More informationAudit and Inspection
Audit and Inspection DIPLOMA COURSE on Research & Development of Products for Public Health Needs Thammasat University, Thailand 28 November, 2008 Dr. Allan K. Johansen, Roche Products Pty Limited, Australia
More informationWMA expert conference on the Revision of the Declaration of Helsinki Cape Town, Vulnerability
WMA expert conference on the Revision of the Declaration of Helsinki Cape Town, 5-7.12.2012 Vulnerability Pr Samia Hurst, MD Institute for Biomedical Ethics Geneva University Medical School samia.hurst@unige.ch
More informationTitle: Investigator Responsibilities. SOP Number: 1501 Effective Date: June 2, 2017
Previous Version Dates: Title: Investigator Responsibilities SOP Number: 1501 Effective Date: June 2, 2017 1 Purpose Investigators are ultimately responsible for the conduct of research. Investigators
More informationGood Clinical Practice. Lisa de Blieck MPA CCRC Clinical Trials Coordination Center
Good Clinical Practice Lisa de Blieck MPA CCRC Clinical Trials Coordination Center Good Clinical Practice (GCP) An international standard for the design, conduct, performance, monitoring, auditing, recording,
More information(Type inside gray boxes, cells will expand) A. EIGHT POINT CRITERIA for IRB Review
Page 1 of 5 IRB Reviewers 8-Point Analysis Form Based on Federal Policy for the Protection of Human Subjects, Criteria for IRB Approval of Research (45 CFR 46.111) Protocol ID #/Title: Date of Review:
More informationHIC Standard Operating Procedure. For-Cause Audits of Human Research Studies
HIC Standard Operating Procedure For-Cause Audits of Human Research Studies Background As part of the Wayne State University (WSU) Human Investigation Committee s (HIC) Human Research Protection Program,
More informationResearch Audits PGR. Effective: 12/04/2013 Reviewed: 12/04/2015. Name of Associated Policy: Palmetto Health Administrative Research Review
Effective: 12/04/2013 Reviewed: 12/04/2015 Name of Associated Policy: Palmetto Health Administrative Research Review Definitions Responsible Positions Equipment Needed Procedure Steps, Guidelines, Rules,
More information140th SESSION OF THE EXECUTIVE COMMITTEE
PAN AMERICAN HEALTH ORGANIZATION WORLD HEALTH ORGANIZATION 14th SESSION OF THE EXECUTIVE COMMITTEE Washington, D.C., USA, 25-29 June 27 Provisional Agenda Item 7.1 CE14/INF/1 (Eng.) 9 May 27 ORIGINAL:
More informationRoles & Responsibilities of Investigator & IRB
Roles & Responsibilities of Investigator & IRB Jaranit Kaewkungwal Mahidol University Regulatory & Guidelines Regulatory & Guidelines GCP & Computer / Database Management Systems International Conference
More information12.0 Investigator Responsibilities
12.0 Investigator Responsibilities 12.1 Policy Investigators are ultimately responsible for the conduct of research. Research must be conducted according to the signed Investigator statement, the investigational
More informationHealth Workforce Planning Techniques and the Policy Context International Health Workforce Collaborative 6 May 2013, Quebec City
Health Workforce Planning Techniques and the Policy Context International Health Workforce Collaborative 6 May 2013, Quebec City Charles Godue Human Resources for Health Antigua & Barbuda Argentina Bahamas
More informationGeneral Procedure - Institutional Review Board
General Procedure - Institutional Review Board Purpose: The primary purpose of the Institutional Review Board (IRB) is to protect the welfare of human subjects used in research. All research requests meeting
More informationSAINT AGNES MEDICAL CENTER CLINICAL RESEARCH CENTER Fresno, California. STANDARD OPERATING PROCEDURES Institutional Review Board
SAINT AGNES MEDICAL CENTER CLINICAL RESEARCH CENTER Fresno, California STANDARD OPERATING PROCEDURES Institutional Review Board Date Effective: April 26, 2001 Index No. R 1217 Date Last Revised: 0 Date
More informationA Principal Investigator s Guide to Responsibilities, Qualifications, Records and Documentation of Human Research University of Kentucky
A Principal Investigator s Guide to Responsibilities, Qualifications, Records and Documentation of Human Research University of Kentucky I. Compliance with IRB and Applicable Federal Requirements A. Investigators
More informationBiomedical IRB MS #
Department for Human Research Protections Institutional Review Boards Biomedical IRB MS # 1035 419-383-6796 IRB.Biomed@utoledo.edu Social, Behavioral and Educational IRB MS # 944 419-530-6167 IRB.SBE@utoledo.edu
More informationUNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER INSTITUTIONAL REVIEW BOARD REPORTING UNANTICIPATED PROBLEMS INCLUDING ADVERSE EVENTS
UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER INSTITUTIONAL REVIEW BOARD REPORTING UNANTICIPATED PROBLEMS INCLUDING ADVERSE EVENTS I. PURPOSE To specify the procedures for reporting unanticipated problems,
More informationInternational Recruitment Solutions. Company profile >
International Recruitment Solutions Company profile > 25.04.2018 1 SOLUTION FOR ALL YOUR INTERNATIONAL HIRING NEEDS Who we are: 1 powerful alliance of 50+ market leading job board companies Unparalleled
More informationGeneral Administration GA STANDARD OPERATING PROCEDURE FOR Sponsor Responsibility and Delegation of Responsibility
General Administration GA 102.01 STANDARD OPERATING PROCEDURE FOR Sponsor Responsibility and Delegation of Responsibility Approval: Nancy Paris, MS, FACHE President and CEO (17 July 2014) (Signature and
More informationHealthcare Practice. Healthcare PanelBook 2017
Healthcare Practice Healthcare PanelBook 2017 Access medical professionals, ailment sufferers and consumers all in one place. Toluna s Healthcare Practice has been providing healthcare and pharmaceutical
More informationStudy Overseas Short-term Mobility Program Scholarships
Template School of Medicine Study Overseas Short-term Mobility Program Scholarships Application Form SOSTMP Scholarship Application Form Electives & Internationalisation Program Level 2 MS 2 Hobart Tel.
More informationThis scholarship is awarded on a first come, first serve basis in accordance with eligibility.
MEMORANDUM TO: FROM: University Students Student Financial Aid and Scholarships DATE: March 09, 2018 RE: Good Neighbor Scholarship Opportunity The and Scholarships will be accepting applications for the
More informationKorean Government Scholarship Program
http://admissions.kdischool.ac.kr 2016 NIIED GKS-KGSP Korean Government Scholarship Program Study Policy at KDI School The remarkable success story of Korea s dynamic economic development and its valuable
More information16 STUDY OVERSIGHT Clinical Quality Management Plans
16 STUDY OVERSIGHT... 1 16.1 Clinical Quality Management Plans... 1 16.2 Site Visits by the LOC, SDMC and LC... 2 16.3 Protocol Team Oversight... 3 16.4 Oversight of Reportable Protocol Deviations... 3
More informationResearch on the Global Impact of the Ronald McDonald House Program
Research on the Global Impact of the Ronald McDonald House Program RMHC: A Global Organization Ronald McDonald House Ronald McDonald Family Room Ronald McDonald Care Mobile 357 203 49 39 countries and
More informationGenesis Health System. Institutional Review Board. Standard Operating Procedures
Genesis Health System Institutional Review Board Table of Contents 1. INSTITUTIONAL AUTHORITY... 6 2. PURPOSE... 6 3. THE SCOPE & AUTHORITY OF THE IRB... 7 Scope...7 Authority of the GHS-IRB...7 Authority
More informationAdvancement Division
Advancement Division The University Advancement Division is composed of two primary functions: Development and Alumni Relations. Through diverse programs and objectives in these two areas a common purpose
More informationINVESTIGATOR GUIDANCE:
INVESTIGATOR GUIDANCE: Investigator Obligations HRP-800 002 28 Sep 2013 Page 1 of 2 1. PURPOSE 1.1. This guidance describes the obligations of investigators conducting overseen by CGIRB
More informationCentral Michigan University Standard Operating Procedures Human Research Protection Program
Central Michigan University Standard Operating Procedures Human Research Protection Program Additional Guidance for Federal Agencies: ED, DoD, DoJ August 2010 September 2016 Edited for AAHRPP Response
More informationLaverne Estañol, M.S., CHRC, CIP, CCRP Assistant Director Human Research Protections
Laverne Estañol, M.S., CHRC, CIP, CCRP Assistant Director Human Research Protections Quality Improvement Activities and Human Subjects Research September 7, 2016 TOPICS What is Quality Improvement (QI)?
More informationHuman Research Protection Program Institutional Review Board
Human Research Protection Program Institutional Review Board Policies and Procedures Guidebook TABLE OF CONTENTS Federal, State and University Regulations Related to the IRB... Section 1.0 Definition of
More informationNOVA SOUTHEASTERN UNIVERSITY
NOVA SOUTHEASTERN UNIVERSITY DIVISION OF RESPONSIBILITIES FOR RESEARCH AND SPONSORED PROGRAMS Vice President of Research & Technology Transfer: The responsibilities of the Vice President of Research &
More informationPer Diem, Travel and Transportation Allowances Committee (PDTATAC) MOVE IN HOUSING ALLOWANCE (MIHA) MEMBERS ONLY
A. General Per Diem, Travel and Transportation Allowances Committee (PDTATAC) MOVE IN HOUSING ALLOWANCE (MIHA) MEMBERS ONLY 1. The following four components comprise MIHA (see par. 10026): a. MIHA/Miscellaneous
More informationDANA-FARBER / HARVARD CANCER CENTER POLICIES FOR HUMAN SUBJECT RESEARCH TITLE:
POLICY #: EDU-100 Page: 1 of 5 1. POLICY STATEMENT: Individuals who participate in research activities overseen by DF/HCC must satisfy specific training requirements in order to conduct human subject research.
More informationEffective Date: April 2014 Revision: September 29, Executive Chair, Co-Chairs, NSHA REB Members, REB Office Personnel, Researchers.
TITLE: Standard Operating Procedure (SOP) External Inspections or Audits NUMBER: NSHA REB-SOP-9-002 Effective Date: April 2014 Revision: September 29, 2017 Applies To: Executive Chair, Co-Chairs, NSHA
More informationOffice of Human Research Office of Human Research Policy and Procedure Manual. Version: 4/4/18
Version: 4/4/18 Signatures on File for the Approval of Revisions to the Policy and Procedures Table of Contents 100 General Administration (GA)... 5 Policy GA 101: The Authority and Purpose of the Institutional
More informationETHICAL AND REGULATORY CONSIDERATIONS
CONSIDERATIONS Office for Office for Human Research Protections The Office for Office for Human Research Protections (OHRP) is an administrative subdivision within the U.S. Department of Health and Human
More informationPROCEDURES GOVERNING HUMAN SUBJECTS RESEARCH
NATIONAL UNIVERSITY PROCEDURES GOVERNING HUMAN SUBJECTS RESEARCH National University Institutional Review Board Approved - September 2011 Suzanne Evans, Committee Chair Roxanne Eisermann Mary Hazzard Charlie
More informationOffice of Human Research Ethics/IRB Standard Operating Procedures
Office of Human Research Ethics/IRB Standard Operating Procedures Effective June 2, 2017 TABLE OF CONTENTS Office of Human Research Ethics/IRB Standard Operating Procedures 101 UNC-Chapel Hill Human Research
More informationOverview ICH GCP E6(R2) Integrated Addendum
2017 Biomedical Research Alliance of New York LLC CITI Program is a division of BRANY Overview ICH GCP E6(R2) Integrated Addendum Introduction On 15 December 2016, the International Council for Harmonistion
More informationImplementing the Revised Common Rule Exemptions with Limited IRB Review
Implementing the Revised Common Rule Exemptions with Limited IRB Review Introduction: Four of the exempt categories in the revised Common Rule include a provision for limited IRB review. This resource
More informationUniversity of Colorado Denver Human Research Protection Program Investigator Responsibilities for the Protection of Human Subjects
Institutional Guidelines The Colorado Multiple Institutional Review Board (COMIRB) recently reviewed and approved your research. The COMIRB reviews research to ensure that the federal regulations for protecting
More informationNational Cancer Institute. Central Institutional Review Board. Standard Operating Procedures
National Cancer Institute Central Institutional Review Board Standard Operating Procedures CIRB Standard Operating Procedures Additional copies are available from the CIRB website (http://www.ncicirb.org)
More informationUnofficial copy not valid
Page 2 (9) CONTENTS 1. PURPOSE... 3 2. DEFINITIONS... 3 3. RESPONSIBILITY... 3 4. INVESTIGATOR SELECTION... 3 4.1 Identification of Investigator s... 3 4.2 Initial Contacts... 4 4.3 Distribution of Pre-Study
More informationOECD Webinar on alternatives to long chain PFCs Co-organized with the Stockholm Convention Secretariat 18 April 2011
OECD Webinar on alternatives to long chain PFCs Co-organized with the Stockholm Convention Secretariat 18 April 2011 Information note Objective: To provide updates on activities related to alternatives
More informationStandard Operating Procedure IRB Review of Research Subject to the Revised Common Rule
HRP Consulting is providing this sample SOP addendum to assist organizations in the event that the revised Common Rule goes into effect on January 19, 2018. This sample SOP addendum does not address every
More informationGeisinger IRB Member Orientation Session 2. Debra L. Henninger, MHS RN CCRC Associate Director, Research Compliance
Geisinger IRB Member Orientation Session 2 Debra L. Henninger, MHS RN CCRC Associate Director, Research Compliance 1 How does the IRB make decisions? Guiding Ethical Principles Regulatory Considerations
More informationFinancing Development, Transfer, and Dissemination of Clean and Environmentally Sound Technologies
Financing Development, Transfer, and Dissemination of Clean and Environmentally Sound Technologies UN General Assembly Structured Dialogues on Technology Facilitation Mechanism April 30, 2014 CIF - BACKGROUND
More informationGood Clinical Practice: A Ground Level View
Good Clinical Practice: A Ground Level View Jeanna Julo, BA, BA, CCRP Assistant Director, Clinical Data Management & Quality Controls, Auditing & Training Clinical Research Administration Research Institute,
More informationDANA-FARBER / HARVARD CANCER CENTER STANDARD OPERATING PROCEDURES FOR HUMAN SUBJECT RESEARCH
SOP #: CON-100 Page: 1 of 9 Effective Date: 2/28/17 1. POLICY STATEMENT: The research team is responsible for obtaining and documenting the informed consent of each subject who participates in research.
More informationThe SOP applies to all human subject research falling under the purview of the University of Missouri Institutional Review Board.
Institutional Review Board.... University of Missouri-Columbia.. Standard Operating Procedure Informed Consent Types and Elements Informed Consent Types and Elements Effective Date: December 12, 2005 Original
More informationPublic Input for Changes to Reportable Events Policy
Public Input for Changes to Reportable Events Policy May 23, 2017 Richard Guido, MD, IRB Chair Jamie Zelazny, PhD, RN, Regulatory Affairs Specialist Outline Regulatory basis for reporting policies Importance
More informationAccessible Americas IV: ICTs for ALL. Session 4. Recent Developments on ICT Accessibility in the Americas Region
Accessible Americas IV: ICTs for ALL Session 4 Recent Developments on ICT Accessibility in the Americas Region The G3ict DARE Index 2017 Preliminary Results San Jose, Costa Rica 21 November 2017 Francesca
More informationPolicy. Subject: Institutional Oversight of Assurance INSTITUTIONAL REVIEW BOARD POLICY NUMBER:
Institutional Review Board Policy DEPARTMENT: POLICY NUMBER: SECTION: REVIEW RESPONSIBILITIES: ORIGINAL CREATION DATE: INSTITUTIONAL REVIEW BOARD I.A IRB Authority and Institutional Commitment IRB Policy
More informationStudy Abroad at Carnegie Mellon University Academic Year Office of International Education
Type of Study Abroad Study Abroad at Carnegie Mellon University Duration of Study Abroad CMU Programs 247 48.6% Academic Year: Direct/External 170 33.5% Academic Year 8 1.6% Exchange Programs Fall 2012
More information1 Introduction to ITC-26. Introduction to the ITC and DEPO. October 24 November 11, 2016 Albuquerque, New Mexico, USA Greg Baum
Introduction to the ITC and DEPO October 24 November 11, 2016 Albuquerque, New Mexico, USA Greg Baum L2 Learning Objectives After completing this module, you should be able to: Recognize the basic goal
More informationIRB 101. Rachel Langhofer Joan Rankin Shapiro Research Administration UA College of Medicine - Phoenix
IRB 101 Rachel Langhofer Joan Rankin Shapiro Research Administration UA College of Medicine - Phoenix Contents Brief discussion of regulations IRB Structure Levels of Approval Informed Consent HIPAA/HITECH
More informationApplication Form. Section A: Project Information. A1. Title of the proposed research project Maximum 250 characters.
Application Form Section A: Project Information A1. Title of the proposed research project Maximum 250 characters. A2. Keywords Provide up to 5 keywords describing the proposed research project. Maximum
More informationPersonnel. Staffing of the Agency's Secretariat. Report by the Director General
Board of Governors General Conference GOV/2017/38-GC(61)/18 Date: 2 August 2017 General Distribution Original: English For official use only Item 8(b)(i) of the Board's provisional agenda (GOV/2017/33)
More informationthe University of Maribor, Slomškov trg 15, 2000 Maribor (further-on: UM)
Based on the agreement with the National Agency»The Centre of the Republic of for Mobility and European Educational and Training Programmes«(CMEPIUS) and the approved funding the University of Maribor,
More informationGCP: Investigator Responsibilities. Susan Tebbs Nicola Kaganson
GCP: Investigator Responsibilities Susan Tebbs Nicola Kaganson Investigator Responsibilities Qualifications & agreements Resources Responsibilities to the subject Ethics The protocol The IMP & randomisation
More informationGCP Inspection by PMDA
2012 EU GCP Inspectors Working Group Workshop London, 12-14 November 2012 Practical Experience in GCP inspections, non EU/EEA countries GCP Inspection by PMDA Kazuko Natsui Inspector for GCP Inspection,
More informationREGULATORY AND FUNDING CHANGES FOR HUMAN SUBJECTS RESEARCH
REGULATORY AND FUNDING CHANGES FOR HUMAN SUBJECTS RESEARCH Teri Reiche Director, IRB and IACUC Jessica Viglione OSP Research Administrator So many acronyms. DHHS = Department of Health and Human Services
More informationResource Document for IRB members
Resource Document for IRB members The purpose of this document is to provide new members and returning members of the Institutional Review Board (IRB) with: (a) An overview of the roles and responsibilities
More informationBCI EMERGING MARKETS SUBSIDY PROGRAM 2014
EMERGING MARKETS SUBSIDY PROGRAM 2014 THE BPO CERTIFICATION INBSTITUTE. UNITED STATES Emerging Markets Subsidy (EMS) Program 2013-14 1. The Objectives of the EMS Program Right from 2007, when the first
More informationPure Michigan Export Program Opening New Doors for Michigan Exporters
Pure Michigan Export Program Opening New Doors for Michigan Exporters Automation Alley January 24, 2013 Jeanne D. Broad International Trade Manager We are reinventing Michigan in a way that works better
More informationINSPIRing Changes to the IRB Process: New templates and more
INSPIRing Changes to the IRB Process: New templates and more John F. Ennever, MD, PhD, CIP Director, Human Research Protection Program Office of Human Research Affairs Boston Medical Center and Boston
More informationGlobal Workforce Trends. Quarterly Market Report September 2017
Global Trends Quarterly Market Report September 2017 Global Table of Contents Global Trends Regional Highlights Detailed Country Level Analysis North, South, & Central America Europe, Middle East, & Africa
More informationWashington University Institutional Review Board Policies and Procedures. April 20, 2015
Washington University Institutional Review Board Policies and Procedures April 20, 2015 Table of Contents I. AUTHORITY AND INSTITUTIONAL COMMITMENT... 2 II. APPLICABILITY: ACTIVITIES SUBJECT TO IRB JURISDICTION...
More informationQ Manpower. Employment Outlook Survey Global. A Manpower Research Report
Manpower Q3 211 Employment Outlook Survey Global A Manpower Research Report Manpower Employment Outlook Survey Global Contents Q3/11 Global Employment Outlook 1 International Comparisons Americas International
More informationAudits/Inspections Be Prepared for Anything
Audits/Inspections Be Prepared for Anything Practices, laboratories, institutions, and clinics that participate in clinical trials are subject to audits by a number of different entities. As a primary
More informationPROMPTLY REPORTABLE EVENTS
PROMPTLY REPORTABLE EVENTS PURPOSE AND SCOPE To define the structure and responsibility for reporting unanticipated problems that occurs during the conduct of research. APPLICABLE REGULATIONS Policy II.02
More informationIRBs IN THE COMMUNITY HOSPITAL SETTING
Harry Shulman, Esq. Davis Wright Tremaine LLP and Cynthia G. Kenny, C.M.S.C., CP, CIM IRB Specialists, Inc. Present IRBs IN THE COMMUNITY HOSPITAL SETTING Second Annual Medical Research Summit March 24-26,
More informationmanaging or activities.
STANDARD OPERATING PROCEDURE Clinical Research Monitoring TITLE: Site Initiation Visit TITLE: Site Initiation Visit 1. PURPOSE SOP Number: Version: 1.0 MICHR CRM MON 002 Effective Date: 19Dec2013 1.1 This
More informationQ Manpower. Employment Outlook Survey Global. A Manpower Research Report
Manpower Q3 2 Employment Outlook Survey Global A Manpower Research Report Manpower Employment Outlook Survey Global Contents Q3/ Global Employment Outlook 1 International Comparisons Americas International
More informationStudy Start-Up SS STANDARD OPERATING PROCEDURE FOR PRE-STUDY SITE VISIT (PSSV)
Replaces previous version 203.01: 01 July 2014 Study Start-Up SS 203.01 STANDARD OPERATING PROCEDURE FOR PRE-STUDY SITE VISIT (PSSV) Approval: Nancy Paris, MS, FACHE President and CEO 24 May 2017 (Signature
More information(PLEASE PRINT) Sex M F Age Birthdate Single Married Widowed Separated Divorced. Business Address Business Phone Cell Phone
(PLEASE PRINT) Emma Warner, MSW, LCSW, ACSW Tulsa, OK 74105 (918) 749-6935 Personal Information Name Address Last Name First Name Initial Home Phone Soc. Sec. # City State Zip Sex M F Age Birthdate Single
More informationWelcome to Bell Reservationless Audio Conferencing. A guide to help you get started with your new Bell service
Welcome to Bell Reservationless Audio Conferencing A guide to help you get started with your new Bell service Contents Welcome to Bell Reservationless Audio Conferencing How to get started with Bell Reservationless
More informationGlobal Program in Occupational Health Practice
Global Program in Occupational Health Practice Linda Forst School of Public Health University of Illinois @ Chicago SCETOH/ICOH. Zagreb. October 28, 2017 No conflicts of interest or financial ties to disclose.
More informationTATA Consultancy Services ACE Career Development Program
TATA Consultancy Services ACE Career Development Program Copyright 2011 Tata Consultancy Services Limited 1 The ACE Program 2 History of AIESEC TCS Partnership 1999-2000 2006 TCS builds Insight2 TCS is
More informationLegally Authorized Representatives in Clinical Trials
Vol. 7, No. 3, March 2011 Can You Handle the Truth? Legally Authorized Representatives in Clinical Trials By Judy Katzen The sickest patients need the best medical care, which might involve participation
More informationSuccessful FDA Inspections at Investigative Sites for Clinical Trials of Drugs and Biologics
Vol. 9, No. 1, January 2013 Happy Trials to You Successful FDA Inspections at Investigative Sites for Clinical Trials of Drugs and Biologics By Swati Tendolkar The United States Food and Drug Administration
More informationFulbright Scholar Research Opportunities
May 01, 2017 Fulbright Scholar Research Opportunities Andy Riess, Ph.D. Assistant Director, Outreach INSTITUTE OF INTERNATIONAL EDUCATION COUNCIL FOR INTERNATIONAL EXCHANGE OF SCHOLARS ariess@iie.org Before
More informationIssues of. Informed Consent. Mitchell E. Parrish, JD, RAC, CIP Regulatory Attorney
Issues of Informed Consent Mitchell E. Parrish, JD, RAC, CIP Regulatory Attorney Part I Part II Regulatory Requirements Key Considerations Part III Elements of Consent Part IV Summary 2 PART I 3 Informed
More informationGrambling State University Application for Human Subjects Review IRB Protocol. 1. Principal Investigator [Last Name, First Name, Middle Initial]
SUBMIT CITI COMPLETION CERTIFICATION WITH FORM 1. Principal Investigator [Last Name, First Name, Middle Initial] Email Phone 2. Department 3. University Status (Check one) a. Faculty b. Staff c. Undergraduate
More informationD Domicile ; H Hospital ; N Non-Domicile ; R Resistance
Sub-section: ALLIED COUNTRIES 15 Mar 2017 1 1.0 PURPOSE Allied Veterans who have wartime service with the Allied Forces who also lived in Canada for at least 10 years, or lived in Canada prior to enlisting
More informationGenerosity of R&D Tax Incentives
Generosity of R&D Tax Incentives Presentation by Jacek Warda TIP Workshop on R&D Tax Treatment in OECD Countries: Comparisons and Evaluations Paris, December 10, 2007 1 Agenda Introduction Measuring R&D
More informationBest Private Bank Awards 2018
Awards 2018 Entry Deadline Extended Until 26 Sept. This deadline is firm and no entries can be accepted past this date In the December issue, Global Finance will publish its selections for the World s
More informationChanges to the Common Rule
Changes to the Common Rule November 21, 2017 S Joseph Austin, JD, LL.M Corey Zolondek, PhD, CIP Introduction: NOTE: Relative to the Common Rule changes, this presentation does not address requirements
More informationQ Manpower. Employment Outlook Survey Global. A Manpower Research Report
Manpower Q1 29 Employment Outlook Survey Global A Manpower Research Report Manpower Employment Outlook Survey Global Contents Q1/9 Global Employment Outlook 1 International Comparisons Americas International
More informationAPPLICATION FOR RESEARCH REQUESTING AN IRB WAIVER OF CONSENT AND HIPAA AUTHORIZATION
FORM W/H-01 APPLICATION FOR RESEARCH REQUESTING AN IRB WAIVER OF CONSENT AND HIPAA AUTHORIZATION Research for which this form is appropriate generally involves only existing patient records or specimens.
More informationUtilizing the NCI CIRB
Policy P15 Written By: B. Laurel Elder, Ph.D. Created: September 2, 2011 Edited Version P15.1 Utilizing the NCI CIRB PURPOSE - The purpose of this Standard Operating Procedure (SOP) is to outline the procedures
More informationDocument Title: Informed Consent for Research Studies
Document Title: Informed Consent for Research Studies Document Number: SOP003 Staff involved in development: Job titles only Document author/owner: Directorate: Department: For use by: RM&G Manager, R&D
More informationHigher Education 2018 INTERNATIONAL FACTS AND FIGURES
Higher Education 2018 INTERNATIONAL FACTS AND FIGURES The UK higher education sector is a global success story. The international diversity we see in our institutions and our academic community, and the
More informationCALL FOR PROJECT PROPOSALS. From AWB Network Universities For capacity building projects in an institution of higher learning in the developing world
February 2018 CALL FOR PROJECT PROPOSALS From AWB Network Universities For capacity building projects in an institution of higher learning in the developing world Academics Without Borders AWB is a bilingual
More information